These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22387267)

  • 1. The extract of Chrysanthemum indicum Linne inhibits EBV LMP1-induced NF-κB activation and the viability of EBV-transformed lymphoblastoid cell lines.
    Kim JE; Jun S; Song M; Kim JH; Song YJ
    Food Chem Toxicol; 2012 May; 50(5):1524-8. PubMed ID: 22387267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lupeol is one of active components in the extract of Chrysanthemum indicum Linne that inhibits LMP1-induced NF-κB activation.
    Kang SC; Lim SY; Song YJ
    PLoS One; 2013; 8(11):e82688. PubMed ID: 24303085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1.
    Thompson MP; Aggarwal BB; Shishodia S; Estrov Z; Kurzrock R
    Leukemia; 2003 Nov; 17(11):2196-201. PubMed ID: 14523478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
    J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
    Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S
    Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV latent membrane protein 1 is a negative regulator of TLR9.
    Fathallah I; Parroche P; Gruffat H; Zannetti C; Johansson H; Yue J; Manet E; Tommasino M; Sylla BS; Hasan UA
    J Immunol; 2010 Dec; 185(11):6439-47. PubMed ID: 20980631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.
    Liebowitz D
    N Engl J Med; 1998 May; 338(20):1413-21. PubMed ID: 9580648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.
    Cahir McFarland ED; Izumi KM; Mosialos G
    Oncogene; 1999 Nov; 18(49):6959-64. PubMed ID: 10602470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of DNA polymerase beta by the LMP1 oncoprotein of EBV through the nuclear factor-kappaB pathway.
    Faumont N; Le Clorennec C; Teira P; Goormachtigh G; Coll J; Canitrot Y; Cazaux C; Hoffmann JS; Brousset P; Delsol G; Feuillard J; Meggetto F
    Cancer Res; 2009 Jun; 69(12):5177-85. PubMed ID: 19491276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent membrane protein 1 regulates STAT1 through NF-kappaB-dependent interferon secretion in Epstein-Barr virus-immortalized B cells.
    Najjar I; Baran-Marszak F; Le Clorennec C; Laguillier C; Schischmanoff O; Youlyouz-Marfak I; Schlee M; Bornkamm GW; Raphaël M; Feuillard J; Fagard R
    J Virol; 2005 Apr; 79(8):4936-43. PubMed ID: 15795279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB only partially mediates Epstein-Barr virus latent membrane protein 1 activation of B cells.
    Liljeholm S; Hughes K; Grundström T; Brodin P
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2117-25. PubMed ID: 9747720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.
    Huen DS; Henderson SA; Croom-Carter D; Rowe M
    Oncogene; 1995 Feb; 10(3):549-60. PubMed ID: 7845680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K.
    Mainou BA; Everly DN; Raab-Traub N
    Oncogene; 2005 Oct; 24(46):6917-24. PubMed ID: 16007144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).
    Eliopoulos AG; Young LS
    Oncogene; 1998 Apr; 16(13):1731-42. PubMed ID: 9582021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of interleukin-1beta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP.
    Krauer KG; Belzer DK; Liaskou D; Buck M; Cross S; Honjo T; Sculley T
    Virology; 1998 Dec; 252(2):418-30. PubMed ID: 9878621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation.
    Izumi KM; Cahir McFarland ED; Ting AT; Riley EA; Seed B; Kieff ED
    Mol Cell Biol; 1999 Aug; 19(8):5759-67. PubMed ID: 10409763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migration.
    Mohr CF; Kalmer M; Gross C; Mann MC; Sterz KR; Kieser A; Fleckenstein B; Kress AK
    Cell Commun Signal; 2014 Jul; 12():46. PubMed ID: 25105941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
    Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
    Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-encoded LMP1 promotes cisplatin-induced caspase activation through JNK and NF-kappaB signaling pathways.
    Zhang X; Sanmun D; Hu L; Fadeel B; Ernberg I
    Biochem Biophys Res Commun; 2007 Aug; 360(1):263-8. PubMed ID: 17586463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.